Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Riedel

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Head & Neck|April 7, 2026
Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer PatientsGeorges E Daoud, Melissa F Riedel, Martha J Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 29, 2010
Soft tissue sarcomaGeorge D Demetri, Scott Antonia, Robert S Benjamin, et al.
The New England Journal of Medicine|December 22, 2018
Sorafenib for Advanced and Refractory Desmoid TumorsMrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, et al.
Science Translational Medicine|January 8, 2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancerMelodi Javid Whitley, Diana M Cardona, Alexander L Lazarides, et al.
The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Soft tissue sarcoma, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelinesMargaret von Mehren, Robert S Benjamin, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Gastrointestinal stromal tumors, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Head & Neck|April 7, 2026
Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer PatientsGeorges E Daoud, Melissa F Riedel, Martha J Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 29, 2010
Soft tissue sarcomaGeorge D Demetri, Scott Antonia, Robert S Benjamin, et al.
The New England Journal of Medicine|December 22, 2018
Sorafenib for Advanced and Refractory Desmoid TumorsMrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, et al.
Science Translational Medicine|January 8, 2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancerMelodi Javid Whitley, Diana M Cardona, Alexander L Lazarides, et al.
The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Soft tissue sarcoma, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelinesMargaret von Mehren, Robert S Benjamin, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Gastrointestinal stromal tumors, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 22